These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs. Berman JD J Infect Dis; 1982 Feb; 145(2):279. PubMed ID: 6274970 [No Abstract] [Full Text] [Related]
3. Late cutaneous leishmaniasis. Hart M; Livingood CS; Goltz RW; Totonchy M Arch Dermatol; 1969 Apr; 99(4):455-8. PubMed ID: 5769330 [No Abstract] [Full Text] [Related]
4. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. Berman JD; Wyler DJ J Infect Dis; 1980 Jul; 142(1):83-6. PubMed ID: 6249874 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous leishmaniasis treatment. Minodier P; Parola P Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous leishmaniasis in the Sudan. Abdalla RE; Ali M; Wasfi AI; el-Hassan AM Trans R Soc Trop Med Hyg; 1973; 67(4):549-59. PubMed ID: 4594461 [No Abstract] [Full Text] [Related]
8. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Mishra M; Biswas UK; Jha DN; Khan AB Lancet; 1992 Nov; 340(8830):1256-7. PubMed ID: 1359322 [TBL] [Abstract][Full Text] [Related]
9. Electron microscopical studies on cutaneous leishmaniasis in Ethiopia. I. The diffuse form and its treatment with pentamidine. Zaar K; Wunderlich F; Belehu A Ann Trop Med Parasitol; 1982 Dec; 76(6):595-605. PubMed ID: 7171248 [No Abstract] [Full Text] [Related]
10. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. Ali A Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830 [TBL] [Abstract][Full Text] [Related]
12. [Various clinical aspects of cutaneous leishmaniasis, a disease too often unrecognized in the Paris area. Diagnostic and therapeutic problems]. Lapierre J; Piguet B; Tran-Vinh-Hien ; Chastanet B Sem Hop; 1975 Feb; 51(8):531-8. PubMed ID: 169586 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of kala-azar]. Neves J Rev Paul Med; 1983; 101(6):237-9. PubMed ID: 6677985 [No Abstract] [Full Text] [Related]
14. Leishmaniasis: early diagnosis is key. Roscoe M JAAPA; 2005 Jul; 18(7):47-50, 53-4. PubMed ID: 16047575 [TBL] [Abstract][Full Text] [Related]
15. Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment. Bryceson AD Trans R Soc Trop Med Hyg; 1970; 64(3):369-79. PubMed ID: 5453496 [No Abstract] [Full Text] [Related]
16. Challenges and new discoveries in the treatment of leishmaniasis. Singh S; Sivakumar R J Infect Chemother; 2004 Dec; 10(6):307-15. PubMed ID: 15614453 [TBL] [Abstract][Full Text] [Related]
17. Mucosal leishmaniasis . Current scenario and prospects for treatment. Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002 [TBL] [Abstract][Full Text] [Related]